Sound waves could help Alzheimer's drugs reach the brain
NCT ID NCT06585384
First seen May 13, 2026 · Last updated May 24, 2026 · Updated 2 times
Summary
This early-phase study tests whether using ultrasound to temporarily open the blood-brain barrier is safe when combined with an anti-inflammatory drug (etanercept) in people with mild Alzheimer's disease. The goal is to help the drug reach the brain more effectively. Only 5 participants will be enrolled to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Fondation Adolphe de Rothschld
RECRUITINGParis, 75019, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.